by William Jester | Oct 20, 2021 | Community, Covid, News
Rutgers has pioneered a decentralized approach to clinical trials that is allowing researchers to accelerate the pace of finding cures, recruit lower-income and underrepresented populations that were previously unable to engage in clinical trials and broaden the...
by William Jester | Oct 19, 2021 | Community, Covid, News
Those who remain unvaccinated against COVID-19 say their biggest concern is vaccine safety, according to a survey from a nationwide coalition of university-based researchers. The survey was taken in June before the U.S. Food and Drug Administration (FDA) changed the...
by William Jester | Oct 19, 2021 | Community, Covid, News
This spring, as mask policies loosened, indoor dining became socially acceptable and most state-to-state travel bans had been lifted, the coronavirus finish line finally appeared to be in sight. The vaccines had arrived and surely would save us all from the disease,...
by Lisette Nazario | Oct 18, 2021 | Covid, News
Immune responses to SARS-CoV-2 Speaker: Akiko Iwasaki, PhD Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology; Investigator, Howard Hughes Medical Institute; Yale School of Medicine. 12:00 – 1:00pm Thursday, November...
by William Jester | Oct 16, 2021 | Community, Covid, News
Johnson & Johnson released data showing a booster dose of its one-shot COVID-19 vaccine generates a stronger immune response and a robust increase in antibodies. According to data from the pharmaceutical company, the extra shot provides 94% protection against the...
